Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 May 11.

Published in final edited form as: Cancer Epidemiol. 2019 Dec 5;64:101647. doi: 10.1016/j.canep.2019.101647

Table 3.

Person-time in years and median overall survival (mOS) in months (IQR), by cohort, treatment, and presence of acute pancreatitis (AP).

	Danish cohort				US cohort

Treatment	AP (n=179)		No AP (n=12,343)		AP (n=2,207)		No AP (n=35,345)

	Person-time	mOS	Person-time	mOS	Person-time	mOS	Person-time	mOS

All patients	188	6.9 (2.0, 15.3)	9,269	3.9 (1.3, 10.8)	19,888	3.9 (1.3, 11.0)	282,920	3.8 (1.3, 9.8)
Best supportive care	51	3.4 (1.4, 8.9)	2,693	2.3 (1.1, 5.4)	6,298	2.7 (1.1, 6.0)	95,521	2.6 (1.2, 5.7)
Oncological treatment	51	7.8 (4.2, 13.0)	3,344	6.7 (2.9, 12.0)	5,481	5.7 (2.1, 11.5)	102,523	5.7 (2.4, 11.1)
Resection +/− oncological	86	39.1 (12.2, -)	3,232	22.4 (10.5, 55.8)	8,109	16.1 (8.5, 43.7)	84,876	16.1 (7.0, 35.2)